Abstract Body

Background: The discovery and isolation of highly potent, broadly neutralizing human antibodies (bnAbs) that recognize a broad diversity of HIV-1 isolates has opened up tremendous opportunities for enhancing our understanding of how HIV-1 can be neutralized. However, it has not been possible until recently to map these antibody responses onto the three-dimensional structure of the HIV-1 Envelope glycoprotein (Env), which enables viral entry into cells, as it has been extraordinarily challenging to produce stable soluble Env trimers with near native antigenicity. Such structural information is essential for rational design of HIV-1 vaccine candidates.

Conclusions: We have recently determined the x-ray structure of a soluble cleaved Env trimer that enabled greater understanding of its function in receptor binding and membrane fusion. Furthermore, mapping of the key neutralizing epitopes in the context of the Env trimer has shown that they are much larger and more complex than previously defined. Many of these antibodies have unique features that enable them to penetrate the glycan shield and bind epitopes that consist of both glycan and protein components. Using a combination of structural and biophysical techniques, we have uncovered various modes of binding and mechanisms of neutralization. Thus, elucidation of the structure and function of the Env trimer and complexes with bnAbs now provides valuable insights for structure-assisted vaccine design. This work was done in collaboration with the labs of Andrew Ward, John Moore and Dennis Burton and was supported by NIH grants P01 AI082362 (HIVRAD), UM1 AI100663 (the Scripps Center for HIV/AIDS Vaccine Immunology and Immunogen Design (CHAVI-ID), R01 AI084817, U54 GM094586 (PSI:Biology) and the International AIDS Vaccine Initiative (IAVI). Recognition of the HIV-1 Env trimer by glycan-dependent bnAbs as revealed by x-ray crystallography. (image created by Jean-Philippe Julien, The Scripps Research Institute)